Therefore, the aim of this meta-analysis is to reassess the potential role of TP53 mutation markers in the course of thyroid cancer, with a special emphasis on differentiated thyroid cancer, which presents a significant epidemiological challenge. This evidence concerns the gene TP53 and thyroid gland carcinoma.